From Wholistic Research & Education Foundation.
Responing to growing interest about CBD from families across the United States, the Autism Society of America and Wholistic Research and Education Foundation have co-costed this educational webinar to discuss whether CBD indeed holds a therapeutic promise for autism and other neurodevelopmental disorders. This webinar brings together renowned MDs and Researchers to explore just how medicinal cannabis therapies can alleviate symptoms in children with autism, and highlights the latest research-driven data driving a groundbreaking multi-disciplinary study on this highly topical issue at the University of California San Diego (UCSD).
ASD, is a complex neurobehavioral condition that includes impairments in social interaction, language, and communication skills combined with rigid, repetitive behaviors. Roughly 30% of those diagnosed with ASD have seizures. Other symptoms may include learning disabilities, ADHD, OCD, depression, or anxiety.
In his first article of the new year, Raphael Mechoulam and other Israeli scientists look at the “real life experiences of medical cannabis treatment in autism.” Published in Nature, the study found that just under a third of patients report significant improvements and over half report moderate improvements while using CBD-rich oil derived from cannabis (30% CBD, 1-2% THC). The improvements include decreased aggression and agitation, fewer seizures, and better sleep, appetite and ability to concentrate.
Anxiety disorders are characterized by excessive nervousness, fear, apprehension, and worry that is out of proportion to the actual danger. OCD, PTSD, panic disorder and phobias are considered anxiety disorders.